Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Peptide Therapeutics Market Growing at 7.16% CAGR to Reach USD 70.20 Bn by 2031 Driven by Rising Cancer Prevalence & Metabolic Disorder Burden, Reports Mordor Intelligence

      Mordor Intelligence Logo

      News provided by

      Mordor Intelligence Private Limited

      Mar 25, 2026, 03:24 ET

      Share this article

      Share this article


      HYDERABAD, India, March 25, 2026 /PRNewswire/ -- According to Mordor Intelligence, the peptide therapeutics market size is valued at USD 49.68 billion in 2026, and is projected to reach USD 70.20 billion by 2031, registering a CAGR of 7.16% over the forecast period (2026–2031), driven by increasing demand for targeted therapies, rising prevalence of chronic diseases, and advancements in peptide synthesis and drug delivery technologies. The growing application of peptide-based drugs across oncology, metabolic disorders, and infectious diseases is supporting widespread adoption across global healthcare systems. 

      The peptide therapeutics market is evolving as pharmaceutical companies increasingly focus on developing highly specific and effective treatment options with improved safety profiles. Peptides offer advantages such as high specificity, low toxicity, and better biological activity, making them suitable for a wide range of therapeutic applications. Continuous innovation in peptide engineering, including modifications to enhance stability and bioavailability, is further strengthening the market landscape. Market growth is also supported by the increasing burden of chronic conditions such as cancer, diabetes, and cardiovascular diseases, which require advanced and targeted treatment approaches. As healthcare systems shift toward precision and personalized medicine, peptide therapeutics are gaining traction as an important class of biologically active compounds. Additionally, advancements in drug delivery technologies, including injectable and oral peptide formulations, are improving patient compliance and expanding clinical use. 

      Peptide Therapeutics Market Share by Region 

      North America represents a significant share of the peptide therapeutics market, driven by strong research and development investments, advanced healthcare infrastructure, and the presence of major pharmaceutical companies. The region continues to lead in innovation and adoption of peptide-based therapies. 

      Europe holds a notable position in the market, supported by growing research initiatives, favorable regulatory frameworks, and increasing focus on advanced therapeutics. 

      Asia-Pacific is emerging as a high-growth region due to rising healthcare expenditure, expanding pharmaceutical manufacturing capabilities, and increasing awareness of advanced treatment options. 

      "Rising clinical adoption of peptide-based therapies reflects steady progress in targeted treatment approaches across multiple indications. This assessment draws on consistently updated datasets and cross-verified sources, offering decision-makers a balanced, evidence-led view aligned with observable market developments," says Soumya Goud, Senior Research Manager, Mordor Intelligence. 

      Peptide Therapeutics Market Trends & Forecast 

      Growing Adoption of Peptide-Based Targeted Therapies: Peptide therapeutics are increasingly being used in targeted treatment approaches due to their high specificity and ability to interact with biological targets effectively, particularly in oncology and metabolic disorders. 

      Advancements in Peptide Synthesis and Drug Delivery Technologies: Innovations in synthesis techniques and delivery systems improve peptide stability, bioavailability, and ease of administration, supporting broader clinical applications. 

      Peptide Therapeutics Market Segmentation Overview 

      By Marketing Type  

      • Branded  
      • Generic  

      By Application  

      • Oncology  
      • Metabolic Disorders  
      • Cardiovascular Disorders  
      • Infectious Diseases  
      • Gastrointestinal Disorders  
      • CNS Disorders  

      By Route of Administration  

      • Parenteral  
      • Oral  
      • Pulmonary & Nasal  
      • Transdermal & Implantable  

      By Technology  

      • Solid-Phase Peptide Synthesis (SPPS)  
      • Liquid-Phase Peptide Synthesis (LPPS)  
      • Hybrid & Flow Chemistry  
      • Recombinant Expression  

      By End User  

      • Hospitals & Clinics  
      • Research Institutes  
      • Pharmaceutical & Biotech Companies 

      By Geography 

      • North America 
        • United States 
        • Canada 
        • Mexico 
      • Europe 
        • Germany 
        • United Kingdom 
        • France 
        • Italy 
        • Spain 
        • Rest of Europe 
      • Asia-Pacific 
        • China 
        • Japan 
        • India 
        • Australia 
        • South Korea 
        • Rest of Asia-Pacific 
      • Middle East & Africa 
        • GCC 
        • South Africa 
        • Rest of Middle East & Africa 
      • South America 
        • Brazil 
        • Argentina 
        • Rest of South America 

      For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/peptide-therapeutics-market?utm_source=prnewswire 

      Peptide Therapeutics Market Competitive Outlook 

      The peptide therapeutics market features a mix of global pharmaceutical companies and specialized biotechnology firms focusing on innovation, pipeline expansion, and strategic collaborations. Market participants are investing in advanced peptide platforms, improving manufacturing capabilities, and expanding their therapeutic portfolios to address evolving healthcare needs. 

      Major Companies include: 

      • Amgen Inc. 
      • AstraZeneca plc 
      • Eli Lilly and Company 
      • F. Hoffmann-La Roche Ltd 
      • Novo Nordisk A/S 
      • Pfizer Inc. 
      • Sanofi S.A. 
      • Takeda Pharmaceutical Company Limited 
      • Teva Pharmaceutical Industries Ltd. 
      • GlaxoSmithKline plc 

      Industry Related Reports by Mordor Intelligence 

      Anesthesia Drugs Market Size - The anesthesia drugs market is projected to grow from USD 7.77 billion in 2026 to USD 9.30 billion by 2031, registering a CAGR of 3.65% during the forecast period. Growth is driven by increasing surgical procedures, rising demand for safe and effective anesthetic agents, and expanding healthcare infrastructure across emerging and developed markets. 

      Baxter International Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Pfizer Inc. and Aspen Pharmacare Holdings Ltd. are the major companies operating in this market. 

      Read more about companies in the anesthesia drugs market: https://www.mordorintelligence.com/industry-reports/global-anesthesia-drugs-market-industry/companies?utm_source=prnewswire 

      India Pharmaceuticals Market Trends - The India pharmaceuticals market is estimated to grow from USD 60.32 billion in 2026 to USD 79.74 billion by 2031, registering a CAGR of 5.74% during the forecast period. Market expansion is supported by strong generic drug manufacturing, increasing domestic demand for medicines, and growing export opportunities across global markets. 

      Sun Pharmaceutical Industries Limited, Cipla Pharmaceuticals, Dr. Reddy's laboratories, Torrent Pharmaceuticals and Cipla Ltd. are the major companies operating in this market. 

      Read more about companies in the India pharmaceuticals market: https://www.mordorintelligence.com/industry-reports/pharmaceuticals-industry-in-india/companies?utm_source=prnewswire 

      Botulinum Toxin Market Share - The botulinum toxin market is expected to grow from USD 13.87 billion in 2026 to USD 20.94 billion by 2031, at a CAGR of 8.59% over the forecast period. Growth is driven by rising demand for aesthetic procedures, increasing therapeutic applications in neurology and dermatology, and expanding awareness of minimally invasive cosmetic treatments. 

      Evolus, AbbVie, Merz, Ipsen Pharma and Galderma are the major companies operating in this market. 

      Read more about companies in the botulinum toxin market: https://www.mordorintelligence.com/industry-reports/global-botulinum-toxin-market/companies?utm_source=prnewswire 

      About Mordor Intelligence: 

      Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.  
        
      With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.  

      For any inquiries, please contact: 
      [email protected]  
      https://www.mordorintelligence.com/contact-us 

      Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

      SOURCE Mordor Intelligence Private Limited

      Modal title

      Also from this source

      Granite Market to Hit USD 24.03 Billion by 2031 with Asia-Pacific Accounting for 48.7% of the Market Revenue, Says Mordor Intelligence

      Granite Market to Hit USD 24.03 Billion by 2031 with Asia-Pacific Accounting for 48.7% of the Market Revenue, Says Mordor Intelligence

      According to Mordor Intelligence, the granite industry size is expected to expand from USD 18.94 billion in 2025 to USD 19.52 billion in 2026,...

      Cell Counting Market Outlook 2031: USD 17.71 Billion Opportunity as Automation and Advanced Cell Analysis Technologies Gain Traction, Reports Mordor Intelligence

      Cell Counting Market Outlook 2031: USD 17.71 Billion Opportunity as Automation and Advanced Cell Analysis Technologies Gain Traction, Reports Mordor Intelligence

      The global cell counting market is estimated to grow from USD 12.39 billion in 2026 to USD 17.71 billion by 2031, registering a CAGR of 7.40% during...

      More Releases From This Source

      Explore

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.